Ondine Biopharma AIM Notification
14 April 2010 - 4:00PM
UK Regulatory
TIDMOBP
Ondine Biopharma AIM Notification
FOR: ONDINE BIOPHARMA CORPORATION
TSX, AIM SYMBOL: OBP
April 14, 2010
Ondine Biopharma AIM Notification
VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 14, 2010) - Ondine Biopharma Corporation (TSX:OBP)(AIM:OBP) ("Ondine" or the "Company") today announces the following transactions by a Director of the Company, and the combined ownership by the Director, the Director's family, and by a charitable foundation of which the Director and the Director's spouse are directors:
/T/
Name Carolyn Cross
Relationship to the Company Director,
Chairman and CEO
Date the transaction was reported to the Company April 13, 2010
Date of trade April 13, 2010
Nature of the transaction Exercise of
Warrants
Type of security acquired Common shares
Number of securities acquired 1,500,000
Price per security Cdn. $0.05
Nature and extent of the above's interest in the transaction 100% direct
ownership
interest
Number of shares held in the Company by the Director 9,607,510
immediately subsequent to completion of the transaction
Percentage direct ownership in the Company of the Director 7.65%
immediately subsequent to completion of the transaction
Number of shares held in the Company by the Director and 21,221,133
Director's family immediately subsequent to completion of
the transaction, together with the shares held by the
Courthill Foundation
Percentage ownership in the Company by the Director and 16.91%
Director's family immediately subsequent to completion of
the transaction, together with the holdings of the Courthill
Foundation (19.74% assuming all options and warrants held by
the director are exercised)
Close period No
Other The 1,500,000
shares acquired
on April 13,
2010 are subject
to a regulatory
hold period in
Canada expiring
April 24, 2010
/T/
-30-
FOR FURTHER INFORMATION PLEASE CONTACT:
Ondine Biopharma Corporation
Carolyn Cross
Chairman and Chief Executive Officer
(604) 669-0555
ccross@ondinebiopharma.com
OR
Canaccord Adams Ltd.
Ryan Gaffney
Nominated Adviser
+4420 7050 6500
Ondine Biopharma Corporation
Ondine Biomed (LSE:OBP)
Historical Stock Chart
From May 2024 to Jun 2024
Ondine Biomed (LSE:OBP)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Ondine Biomed (London Stock Exchange): 0 recent articles
More Ondine Bio. News Articles